個人中心
登出
中文繁體
返回
登入後諮詢在線客服
回到頂部

子公司更新/資訊

$Evogene (EVGN.US)$ Lavie Bio獲得以色列創新局的補助款,推進“MicroFermentor”技術的開發,這是一項可以改變農業生物的經濟的獨特技術
37分鐘前,東部時間上午7點
透過PR NEWSWIRE
該技術旨在降低應用成本,延長產品保存期限,並在田間應用後延長細菌的生存能力
2024年9月30日,以色列,REHOVot / PRNewswire - Lavie Bio Ltd.,一家領先的農業生物公司,為evogene ltd(納斯達克代號: EVGN) (TASE: EVGN), announced receiving a grant from the Israel Innovation Authority (IIA) to advance its program to develop a breakthrough technology for the delivery of ag-biologicals to agriculture. This patented technology, named 'MicroFermentor', is based on an innovative microbe formulation that enables the multiplication of beneficial bacteria directly on the plant, reducing application costs, extending shelf life, and prolonging the bacteria's viability after field application. The grant was awarded following positive initial microbe encapsulation and greenhouse validation experiments and will support the program's next phase of development toward commercialization.
免責聲明:社區由Moomoo Technologies Inc.提供,僅用於教育目的。 更多信息
3
+0
原文
舉報
瀏覽 4773
評論
登錄發表評論